Immix Biopharma, INC. (IMMX) — DEF 14A Filings
All DEF 14A filings from Immix Biopharma, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Immix Biopharma Files Definitive Proxy Statement
— Apr 30, 2025 Risk: low
Immix Biopharma, Inc. filed its definitive proxy statement (DEF 14A) on April 30, 2025, for the fiscal year ending December 31, 2024. The filing indicates no fe -
Immix Biopharma, Inc. Announces Annual Meeting of Stockholders on June 11, 2024
— Apr 29, 2024 Risk: low
Immix Biopharma, Inc. (IMMX) filed a Proxy Statement (DEF 14A) with the SEC on April 29, 2024. Immix Biopharma, Inc. will hold its Annual Meeting of Stockholder
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX